AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CYBN
  4. [6-K] Cybin Inc. Current Report (Foreign Issuer)

[6-K] Cybin Inc. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source:

Stock CYBN logo
Cybin Inc

NYSE:CYBN

CYBN Rankings

#6019 Ranked by Market Cap
N/A Ranked by Dividends

CYBN Latest News

Aug 7, 2025
Cybin Receives European Approval for EMBRACE, a Multinational Phase 3 Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
Aug 6, 2025
Cybin to Participate in the Canaccord Genuity 45th Annual Growth Conference
Jul 17, 2025
Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
Jul 1, 2025
REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
Jun 30, 2025
Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights

CYBN Latest SEC Filings

Aug 7, 2025
[6-K] Cybin Inc. Current Report (Foreign Issuer)
Aug 6, 2025
[6-K] Cybin Inc. Current Report (Foreign Issuer)
Jul 28, 2025
[6-K] Cybin Inc. Current Report (Foreign Issuer)
Jul 14, 2025
[6-K] Cybin Inc. Current Report (Foreign Issuer)
Jul 14, 2025
[SUPPL] Cybin Inc. SEC Filing

CYBN Stock Data

175.98M
19.22M
107.88%
42.44%
9.45%
Biotechnology
Healthcare
Canada
Toronto